Miyakogusa Predicted Gene
- Lj0g3v0294679.1
BLASTP 2.2.25 [Feb-01-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= Lj0g3v0294679.1 Non Characterized Hit- tr|I1JL05|I1JL05_SOYBN
Uncharacterized protein OS=Glycine max GN=Gma.45135
PE,63.16,2e-19,coiled-coil,NULL,CUFF.19737.1
(87 letters)
Database: Medicago_aa4.0v1
62,319 sequences; 21,947,249 total letters
Searching..................................................done
Score E
Sequences producing significant alignments: (bits) Value
Medtr5g095910.1 | LRR and NB-ARC domain disease resistance prote... 134 1e-32
Medtr2g014840.1 | LRR and NB-ARC domain disease resistance prote... 133 4e-32
Medtr2g014820.1 | NB-ARC domain disease resistance protein | LC ... 129 8e-31
Medtr2g014730.1 | NB-ARC domain disease resistance protein | HC ... 120 2e-28
Medtr2g014830.1 | NB-LRR type disease resistance protein | HC | ... 114 2e-26
Medtr3g020890.1 | NB-ARC domain disease resistance protein | LC ... 101 1e-22
Medtr2g063777.1 | LRR and NB-ARC domain disease resistance prote... 91 2e-19
Medtr3g032960.1 | LRR and NB-ARC domain disease resistance prote... 89 7e-19
Medtr3g435740.1 | NB-ARC domain disease resistance protein, puta... 87 2e-18
Medtr3g035960.2 | NB-ARC domain disease resistance protein, puta... 87 3e-18
Medtr3g035960.1 | NB-ARC domain disease resistance protein, puta... 87 3e-18
Medtr3g035960.3 | NB-ARC domain disease resistance protein, puta... 87 3e-18
Medtr6g084550.1 | LRR and NB-ARC domain disease resistance prote... 87 3e-18
Medtr3g014390.1 | LRR and NB-ARC domain disease resistance prote... 87 3e-18
Medtr3g028040.1 | LRR and NB-ARC domain disease resistance prote... 87 4e-18
Medtr3g032370.1 | LRR and NB-ARC domain disease resistance prote... 87 4e-18
Medtr3g033240.1 | LRR and NB-ARC domain disease resistance prote... 87 4e-18
Medtr0267s0070.1 | NB-ARC domain disease resistance protein, put... 87 5e-18
Medtr3g014360.1 | LRR and NB-ARC domain disease resistance prote... 86 6e-18
Medtr3g435720.1 | LRR and NB-ARC domain disease resistance prote... 86 7e-18
Medtr3g032800.1 | LRR and NB-ARC domain disease resistance prote... 86 9e-18
Medtr0083s0110.1 | CC-NBS-LRR resistance protein, putative | HC ... 86 1e-17
Medtr4g050410.1 | LRR and NB-ARC domain disease resistance prote... 85 2e-17
Medtr3g033110.1 | NB-ARC domain disease resistance protein, puta... 85 2e-17
Medtr3g032150.1 | LRR and NB-ARC domain disease resistance prote... 84 3e-17
Medtr3g007190.1 | NB-ARC domain disease resistance protein | LC ... 84 3e-17
Medtr3g014510.1 | LRR and NB-ARC domain disease resistance prote... 84 3e-17
Medtr3g033080.1 | NBS-LRR type disease resistance protein | LC |... 84 4e-17
Medtr3g014470.1 | LRR and NB-ARC domain disease resistance prote... 83 5e-17
Medtr3g019040.1 | disease resistance protein (CC-NBS-LRR class) ... 81 2e-16
Medtr8g030860.1 | LRR and NB-ARC domain disease resistance prote... 81 3e-16
Medtr3g030960.1 | LRR and NB-ARC domain disease resistance prote... 79 8e-16
Medtr3g030980.1 | LRR and NB-ARC domain disease resistance prote... 79 1e-15
Medtr3g018980.1 | disease resistance protein (CC-NBS-LRR class) ... 79 1e-15
Medtr3g018980.2 | disease resistance protein (CC-NBS-LRR class) ... 78 2e-15
Medtr3g035940.5 | LRR and NB-ARC domain disease resistance prote... 77 4e-15
Medtr3g035940.4 | LRR and NB-ARC domain disease resistance prote... 77 4e-15
Medtr3g035940.2 | LRR and NB-ARC domain disease resistance prote... 77 4e-15
Medtr3g035940.1 | LRR and NB-ARC domain disease resistance prote... 77 4e-15
Medtr3g035940.3 | LRR and NB-ARC domain disease resistance prote... 77 4e-15
Medtr3g032500.2 | LRR and NB-ARC domain disease resistance prote... 77 4e-15
Medtr3g032500.1 | LRR and NB-ARC domain disease resistance prote... 77 4e-15
Medtr3g031940.1 | LRR and NB-ARC domain disease resistance prote... 77 4e-15
Medtr3g034380.1 | LRR and NB-ARC domain disease resistance prote... 77 4e-15
Medtr3g032200.1 | LRR and NB-ARC domain disease resistance prote... 77 4e-15
Medtr3g033130.1 | NB-ARC domain disease resistance protein, puta... 77 5e-15
Medtr0002s0090.1 | LRR and NB-ARC domain disease resistance prot... 77 5e-15
Medtr3g035500.1 | LRR and NB-ARC domain disease resistance prote... 77 5e-15
Medtr3g033380.1 | LRR and NB-ARC domain disease resistance prote... 77 5e-15
Medtr3g032110.1 | LRR and NB-ARC domain disease resistance prote... 76 8e-15
Medtr3g018930.1 | LRR and NB-ARC domain disease resistance prote... 76 8e-15
Medtr3g033860.1 | LRR and NB-ARC domain disease resistance prote... 75 9e-15
Medtr3g018930.2 | LRR and NB-ARC domain disease resistance prote... 75 1e-14
Medtr8g038590.1 | NBS-LRR type disease resistance protein | HC |... 75 1e-14
Medtr8g038570.1 | NBS-LRR type disease resistance protein | HC |... 75 1e-14
Medtr3g014040.1 | LRR and NB-ARC domain disease resistance prote... 74 2e-14
Medtr3g033160.1 | hypothetical protein | LC | chr3:10539695-1054... 74 3e-14
Medtr3g034430.1 | LRR and NB-ARC domain disease resistance prote... 74 4e-14
Medtr3g014530.1 | CC-NBS-LRR resistance protein, putative | LC |... 73 5e-14
Medtr3g014320.1 | LRR and NB-ARC domain disease resistance prote... 73 7e-14
Medtr3g032340.1 | LRR and NB-ARC domain disease resistance prote... 72 1e-13
Medtr3g014080.1 | LRR and NB-ARC domain disease resistance prote... 72 1e-13
Medtr3g014080.2 | LRR and NB-ARC domain disease resistance prote... 72 1e-13
Medtr0003s0170.1 | NB-ARC domain disease resistance protein | HC... 71 2e-13
Medtr1g037730.1 | NB-ARC domain disease resistance protein | HC ... 71 2e-13
Medtr1g047800.1 | disease resistance protein (CC-NBS-LRR class) ... 71 2e-13
Medtr2g039090.1 | NBS-LRR type disease resistance protein | LC |... 71 3e-13
Medtr3g019000.2 | disease resistance protein (CC-NBS-LRR class) ... 70 4e-13
Medtr3g019000.1 | disease resistance protein (CC-NBS-LRR class) ... 70 4e-13
Medtr3g035480.1 | LRR and NB-ARC domain disease resistance prote... 70 4e-13
Medtr0002s0110.1 | LRR and NB-ARC domain disease resistance prot... 70 4e-13
Medtr3g035840.1 | NB-ARC domain disease resistance protein | HC ... 70 5e-13
Medtr3g035840.2 | NB-ARC domain disease resistance protein | HC ... 70 5e-13
Medtr3g032760.1 | LRR and NB-ARC domain disease resistance prote... 69 1e-12
Medtr0005s0200.1 | NBS-LRR type disease resistance protein | HC ... 67 3e-12
Medtr1g037610.1 | LRR and NB-ARC domain disease resistance prote... 67 4e-12
Medtr3g015260.1 | disease resistance protein (CC-NBS-LRR class) ... 66 6e-12
Medtr3g015260.2 | disease resistance protein (CC-NBS-LRR class) ... 66 7e-12
Medtr7g078790.1 | LRR and NB-ARC domain disease resistance prote... 66 8e-12
Medtr3g014500.1 | NB-ARC domain disease resistance protein, puta... 66 9e-12
Medtr5g037590.1 | LRR and NB-ARC domain disease resistance prote... 60 4e-10
Medtr1g008240.1 | NB-ARC domain disease resistance protein | LC ... 57 5e-09
Medtr3g022600.1 | LRR and NB-ARC domain disease resistance prote... 56 6e-09
Medtr3g025360.1 | NB-ARC domain disease resistance protein, puta... 56 9e-09
Medtr3g022790.1 | LRR and NB-ARC domain disease resistance prote... 56 1e-08
Medtr2g038760.1 | NBS-LRR type disease resistance protein | LC |... 56 1e-08
Medtr3g021100.2 | disease resistance protein (CC-NBS-LRR class) ... 54 3e-08
Medtr3g021100.1 | disease resistance protein (CC-NBS-LRR class) ... 54 3e-08
Medtr3g027250.1 | LRR and NB-ARC domain disease resistance prote... 54 4e-08
Medtr3g027250.2 | LRR and NB-ARC domain disease resistance prote... 54 4e-08
Medtr3g027250.3 | LRR and NB-ARC domain disease resistance prote... 54 4e-08
Medtr3g035810.1 | LRR and NB-ARC domain disease resistance prote... 54 4e-08
Medtr0425s0020.1 | LRR and NB-ARC domain disease resistance prot... 54 5e-08
Medtr0425s0020.2 | LRR and NB-ARC domain disease resistance prot... 54 5e-08
Medtr3g022300.1 | LRR and NB-ARC domain disease resistance prote... 53 5e-08
Medtr2g039040.1 | NBS-LRR type disease resistance protein | LC |... 53 6e-08
Medtr1g045960.1 | NB-ARC domain disease resistance protein | LC ... 53 6e-08
Medtr3g023030.3 | LRR and NB-ARC domain disease resistance prote... 53 7e-08
Medtr3g022940.1 | LRR and NB-ARC domain disease resistance prote... 53 7e-08
Medtr3g022130.1 | LRR and NB-ARC domain disease resistance prote... 53 7e-08
Medtr3g023030.1 | LRR and NB-ARC domain disease resistance prote... 53 7e-08
Medtr3g023030.2 | LRR and NB-ARC domain disease resistance prote... 53 7e-08
Medtr3g027200.1 | NB-ARC domain disease resistance protein | LC ... 53 8e-08
Medtr2g038900.1 | NBS-LRR type disease resistance protein | LC |... 53 8e-08
Medtr7g021000.1 | disease resistance protein (CC-NBS-LRR class) ... 52 9e-08
Medtr3g070590.1 | LRR and NB-ARC domain disease resistance prote... 52 1e-07
Medtr3g071130.2 | LRR and NB-ARC domain disease resistance prote... 52 1e-07
Medtr3g071130.1 | LRR and NB-ARC domain disease resistance prote... 52 1e-07
Medtr7g021000.2 | disease resistance protein (CC-NBS-LRR class) ... 52 1e-07
Medtr3g021340.1 | LRR and NB-ARC domain disease resistance prote... 52 1e-07
Medtr3g022400.1 | disease resistance protein (CC-NBS-LRR class) ... 52 1e-07
Medtr3g022400.2 | disease resistance protein (CC-NBS-LRR class) ... 52 1e-07
Medtr3g021380.1 | NBS-LRR type disease resistance protein | LC |... 52 1e-07
Medtr7g089080.1 | cyclin | HC | chr7:34806771-34800306 | 20130731 51 2e-07
Medtr3g022230.3 | NB-ARC domain disease resistance protein, puta... 51 2e-07
Medtr3g022230.4 | NB-ARC domain disease resistance protein, puta... 51 2e-07
Medtr3g022230.2 | NB-ARC domain disease resistance protein, puta... 51 2e-07
Medtr3g022230.1 | NB-ARC domain disease resistance protein, puta... 51 2e-07
Medtr3g022230.5 | NB-ARC domain disease resistance protein, puta... 51 2e-07
Medtr3g027420.1 | NBS-LRR type disease resistance protein | LC |... 51 3e-07
Medtr3g022920.1 | disease resistance protein (CC-NBS-LRR class) ... 50 5e-07
Medtr3g021170.1 | LRR and NB-ARC domain disease resistance prote... 50 5e-07
Medtr8g011300.1 | NBS-LRR type disease resistance protein | LC |... 49 1e-06
Medtr3g026660.2 | NB-ARC domain disease resistance protein | HC ... 48 2e-06
Medtr3g026660.1 | NB-ARC domain disease resistance protein | HC ... 48 3e-06
Medtr3g021400.1 | disease resistance protein (CC-NBS-LRR class) ... 47 3e-06
Medtr8g011550.1 | NB-ARC domain disease resistance protein | LC ... 47 3e-06
Medtr5g072140.1 | NB-ARC domain disease resistance protein | HC ... 46 8e-06
>Medtr5g095910.1 | LRR and NB-ARC domain disease resistance
protein | HC | chr5:41932381-41936151 | 20130731
Length = 1242
Score = 134 bits (338), Expect = 1e-32, Method: Composition-based stats.
Identities = 67/78 (85%), Positives = 73/78 (93%), Gaps = 1/78 (1%)
Query: 1 MAAV-VGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQ 59
MAAV VGEAFLSAFIEVV+D+LASPE ++ IRGKK+D NL+QRLKNTLYAVEAVLNDAEQ
Sbjct: 1 MAAVAVGEAFLSAFIEVVLDRLASPEVIDLIRGKKVDVNLIQRLKNTLYAVEAVLNDAEQ 60
Query: 60 KQIKDSAVNKWLDDLKDA 77
KQ KDSAVNKWLDDLKDA
Sbjct: 61 KQFKDSAVNKWLDDLKDA 78
>Medtr2g014840.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr2:4315783-4311787 | 20130731
Length = 1250
Score = 133 bits (334), Expect = 4e-32, Method: Composition-based stats.
Identities = 65/76 (85%), Positives = 70/76 (92%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AAVVGEAFLSAFIEVV+DKL+SPE V+ IRGKK+ NL+QRLKNTLYAVEAVLND EQKQ
Sbjct: 3 AAVVGEAFLSAFIEVVLDKLSSPEVVDLIRGKKVAVNLIQRLKNTLYAVEAVLNDTEQKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
KDSAVNKWLDDLKDA
Sbjct: 63 FKDSAVNKWLDDLKDA 78
>Medtr2g014820.1 | NB-ARC domain disease resistance protein | LC |
chr2:4306971-4301435 | 20130731
Length = 884
Score = 129 bits (323), Expect = 8e-31, Method: Composition-based stats.
Identities = 64/75 (85%), Positives = 71/75 (94%)
Query: 3 AVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQI 62
AVVGE+FLSAFIEVV+D+LASPE V+ IRGKK+D NL+QRLKNTLYAVEAVLNDAEQKQ+
Sbjct: 4 AVVGESFLSAFIEVVLDRLASPEVVDLIRGKKVDVNLVQRLKNTLYAVEAVLNDAEQKQL 63
Query: 63 KDSAVNKWLDDLKDA 77
KDSAV KWLDDLKDA
Sbjct: 64 KDSAVIKWLDDLKDA 78
>Medtr2g014730.1 | NB-ARC domain disease resistance protein | HC |
chr2:4252897-4257728 | 20130731
Length = 1215
Score = 120 bits (302), Expect = 2e-28, Method: Composition-based stats.
Identities = 57/73 (78%), Positives = 65/73 (89%)
Query: 3 AVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQI 62
A VGEAFLSAFIEVV+D+LASPE V IRGKK+D NL+QRLKNTLYAVEAV NDAEQKQ
Sbjct: 4 AAVGEAFLSAFIEVVLDRLASPEVVVLIRGKKVDVNLVQRLKNTLYAVEAVFNDAEQKQF 63
Query: 63 KDSAVNKWLDDLK 75
K+ A+N+W+DDLK
Sbjct: 64 KNPAINRWIDDLK 76
>Medtr2g014830.1 | NB-LRR type disease resistance protein | HC |
chr2:4309555-4307568 | 20130731
Length = 162
Score = 114 bits (286), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 57/76 (75%), Positives = 65/76 (85%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AA VGEAFLS IEVV+D+LASP+ ++FI GKK+ NL+QRL NTLYAVEAVLND EQKQ
Sbjct: 3 AAAVGEAFLSLLIEVVLDRLASPQVLDFIHGKKVYINLVQRLNNTLYAVEAVLNDVEQKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
KDSA+ KWLDDLKDA
Sbjct: 63 FKDSAIKKWLDDLKDA 78
>Medtr3g020890.1 | NB-ARC domain disease resistance protein | LC |
chr3:6060991-6057172 | 20130731
Length = 1248
Score = 101 bits (252), Expect = 1e-22, Method: Composition-based stats.
Identities = 50/75 (66%), Positives = 57/75 (76%)
Query: 3 AVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQI 62
AV+G AFLSAF +VV +LASPE N I G KLD LLQRL+ TL V AVLNDAE+KQ
Sbjct: 4 AVIGGAFLSAFFDVVFKRLASPEVANLILGNKLDKKLLQRLETTLRVVRAVLNDAEKKQT 63
Query: 63 KDSAVNKWLDDLKDA 77
+DS VN WL+DLKDA
Sbjct: 64 RDSDVNNWLNDLKDA 78
>Medtr2g063777.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr2:26906267-26910067 | 20130731
Length = 1266
Score = 90.9 bits (224), Expect = 2e-19, Method: Composition-based stats.
Identities = 40/76 (52%), Positives = 62/76 (81%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AA++GEAFLSA ++ +++KL S +F+++I+ KL+ +LL++LK TL ++ VL+DAE+KQ
Sbjct: 3 AAMIGEAFLSAIVQTLVEKLVSTQFLDYIKNTKLNVSLLRQLKTTLLTLQVVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + AV +WLDDLKDA
Sbjct: 63 INNPAVKQWLDDLKDA 78
>Medtr3g032960.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:10434947-10429930 | 20130731
Length = 1270
Score = 89.4 bits (220), Expect = 7e-19, Method: Composition-based stats.
Identities = 41/76 (53%), Positives = 60/76 (78%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A ++G AFLSA ++ +++KLAS EF ++I+ KL+D+LL++LK TL ++ VL+DAE+KQ
Sbjct: 3 ATMIGGAFLSATVQTLVEKLASKEFRDYIKNTKLNDSLLRQLKTTLLTLQVVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I AV +WLDDLKDA
Sbjct: 63 INKPAVKQWLDDLKDA 78
>Medtr3g435740.1 | NB-ARC domain disease resistance protein,
putative | LC | chr3:11782826-11778460 | 20130731
Length = 1313
Score = 87.4 bits (215), Expect = 2e-18, Method: Composition-based stats.
Identities = 44/76 (57%), Positives = 56/76 (73%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AA+VG AFLSA I+ + +KL S EF F++ KL+ + L LK TL+A++AVL DAEQKQ
Sbjct: 48 AALVGGAFLSATIQTIAEKLTSSEFRGFVKNTKLNYSQLAELKTTLFALQAVLVDAEQKQ 107
Query: 62 IKDSAVNKWLDDLKDA 77
KD V +WLDDLKDA
Sbjct: 108 FKDLPVKQWLDDLKDA 123
>Medtr3g035960.2 | NB-ARC domain disease resistance protein,
putative | HC | chr3:13343459-13347214 | 20130731
Length = 1251
Score = 87.4 bits (215), Expect = 3e-18, Method: Composition-based stats.
Identities = 41/76 (53%), Positives = 58/76 (76%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ +++KLAS EF ++IR KL+ +L L+ TL A++AVL+DAE KQ
Sbjct: 3 ATLVGGAFLSATVQTLVEKLASQEFCDYIRNTKLNSSLFAELETTLLALQAVLDDAEHKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I ++AV +WLD LKDA
Sbjct: 63 ITNTAVKQWLDQLKDA 78
>Medtr3g035960.1 | NB-ARC domain disease resistance protein,
putative | HC | chr3:13343459-13347214 | 20130731
Length = 1251
Score = 87.4 bits (215), Expect = 3e-18, Method: Composition-based stats.
Identities = 41/76 (53%), Positives = 58/76 (76%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ +++KLAS EF ++IR KL+ +L L+ TL A++AVL+DAE KQ
Sbjct: 3 ATLVGGAFLSATVQTLVEKLASQEFCDYIRNTKLNSSLFAELETTLLALQAVLDDAEHKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I ++AV +WLD LKDA
Sbjct: 63 ITNTAVKQWLDQLKDA 78
>Medtr3g035960.3 | NB-ARC domain disease resistance protein,
putative | HC | chr3:13343459-13347214 | 20130731
Length = 1251
Score = 87.4 bits (215), Expect = 3e-18, Method: Composition-based stats.
Identities = 41/76 (53%), Positives = 58/76 (76%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ +++KLAS EF ++IR KL+ +L L+ TL A++AVL+DAE KQ
Sbjct: 3 ATLVGGAFLSATVQTLVEKLASQEFCDYIRNTKLNSSLFAELETTLLALQAVLDDAEHKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I ++AV +WLD LKDA
Sbjct: 63 ITNTAVKQWLDQLKDA 78
>Medtr6g084550.1 | LRR and NB-ARC domain disease resistance
protein | HC | chr6:31680438-31677766 | 20130731
Length = 873
Score = 87.4 bits (215), Expect = 3e-18, Method: Composition-based stats.
Identities = 42/76 (55%), Positives = 58/76 (76%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ ++D+L SPEF NFI KKL+ +LL+ L+ TL + AVL+DAE+KQ
Sbjct: 3 ATLVGGAFLSASVQTIMDRLTSPEFRNFINNKKLNLSLLKHLETTLLTLHAVLDDAEKKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + V +WLD+LKDA
Sbjct: 63 INNLPVKQWLDELKDA 78
>Medtr3g014390.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:4093243-4088308 | 20130731
Length = 1354
Score = 87.0 bits (214), Expect = 3e-18, Method: Composition-based stats.
Identities = 42/77 (54%), Positives = 59/77 (76%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +VGE LSA +++++ K+ S EF+NF R KLD LL +LK TL +++AVLNDAE+K
Sbjct: 1 MATIVGEGILSASVKLLLQKIVSGEFINFFRNMKLDVPLLDKLKITLLSLQAVLNDAEEK 60
Query: 61 QIKDSAVNKWLDDLKDA 77
QI +SAV +WL+ L+DA
Sbjct: 61 QIANSAVKEWLNMLQDA 77
>Medtr3g028040.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:8860656-8864414 | 20130731
Length = 1252
Score = 87.0 bits (214), Expect = 4e-18, Method: Composition-based stats.
Identities = 41/76 (53%), Positives = 60/76 (78%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ ++D+L S EF +FI +KL+ +LL++L+ TL ++AVL+DAE+KQ
Sbjct: 3 ATLVGGAFLSASVQTMLDQLTSTEFRDFINNRKLNVSLLKQLQATLLVLQAVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + AV +WLDDLKDA
Sbjct: 63 INNRAVKQWLDDLKDA 78
>Medtr3g032370.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:10194663-10200244 | 20130731
Length = 1335
Score = 86.7 bits (213), Expect = 4e-18, Method: Composition-based stats.
Identities = 41/75 (54%), Positives = 58/75 (77%)
Query: 3 AVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQI 62
A +G AFLSA I+ +++KLAS EF ++I+ KL+ +LL++LK TL ++ VL+DAE+KQI
Sbjct: 2 AAIGSAFLSATIQTLVEKLASTEFRDYIKNTKLNVSLLRQLKTTLLTLQVVLDDAEEKQI 61
Query: 63 KDSAVNKWLDDLKDA 77
+ AV WLDDLKDA
Sbjct: 62 NNPAVKLWLDDLKDA 76
>Medtr3g033240.1 | LRR and NB-ARC domain disease resistance
protein, putative | LC | chr3:10579971-10583761 |
20130731
Length = 1232
Score = 86.7 bits (213), Expect = 4e-18, Method: Composition-based stats.
Identities = 40/76 (52%), Positives = 60/76 (78%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A ++G AFLSA ++ +++KLAS EF+++I+ KL+ +LL++LK TL ++ VL+DAE+KQ
Sbjct: 3 ATMIGGAFLSATVQTLVEKLASTEFLDYIKNTKLNVSLLRQLKTTLLTLQVVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + AV WLDDLKDA
Sbjct: 63 INNPAVKLWLDDLKDA 78
>Medtr0267s0070.1 | NB-ARC domain disease resistance protein,
putative | LC | scaffold0267:17737-24509 | 20130731
Length = 1982
Score = 86.7 bits (213), Expect = 5e-18, Method: Composition-based stats.
Identities = 48/76 (63%), Positives = 65/76 (85%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA+VV EAFLSAF+EV+++K+ S EFVNFIR KKLD +LL++LK TL +++AVLNDAE+K
Sbjct: 1 MASVVAEAFLSAFVEVLLEKMISTEFVNFIRSKKLDISLLEKLKLTLLSLQAVLNDAEEK 60
Query: 61 QIKDSAVNKWLDDLKD 76
QI + AV +WL +L+D
Sbjct: 61 QITNPAVKQWLGNLRD 76
>Medtr3g014360.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:4081120-4077089 | 20130731
Length = 1291
Score = 86.3 bits (212), Expect = 6e-18, Method: Composition-based stats.
Identities = 41/77 (53%), Positives = 58/77 (75%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +VGEAFL+A ++V++ K+ S EF + R KLD LL++L TL +++AVLNDAE+K
Sbjct: 1 MATIVGEAFLTASLKVLLQKIVSGEFADLFRSTKLDVPLLEKLNITLMSLQAVLNDAEEK 60
Query: 61 QIKDSAVNKWLDDLKDA 77
QI + AV +WLD L+DA
Sbjct: 61 QITNPAVKQWLDLLRDA 77
>Medtr3g435720.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:11768604-11772545 | 20130731
Length = 1269
Score = 86.3 bits (212), Expect = 7e-18, Method: Composition-based stats.
Identities = 40/76 (52%), Positives = 61/76 (80%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A ++G AFLSA ++ + +KLAS EF+++I+ KL+ +LL++LK TL ++AVL+DAE+KQ
Sbjct: 3 ATMIGGAFLSATMQTLFEKLASTEFLDYIKNTKLNVSLLRQLKTTLLTLQAVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
+ + AV +WLDDLKDA
Sbjct: 63 MNNLAVKQWLDDLKDA 78
>Medtr3g032800.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:10376544-10372801 | 20130731
Length = 1247
Score = 85.5 bits (210), Expect = 9e-18, Method: Composition-based stats.
Identities = 39/76 (51%), Positives = 61/76 (80%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A ++G AFLSA ++ +++KLAS EF+++I+ KL+ +LL++LK TL ++ VL+DAE+KQ
Sbjct: 3 ATMIGGAFLSATVQTLVEKLASTEFLDYIKNTKLNVSLLRQLKTTLLTLQVVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + +V +WLDDLKDA
Sbjct: 63 IINPSVKQWLDDLKDA 78
>Medtr0083s0110.1 | CC-NBS-LRR resistance protein, putative | HC |
scaffold0083:50660-49974 | 20130731
Length = 176
Score = 85.5 bits (210), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 40/76 (52%), Positives = 61/76 (80%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AA++G AFL+A ++ +++KLAS EF+++I+ KL+ +LL++LK TL ++ VL+DAE+KQ
Sbjct: 3 AAMIGGAFLTATVQTLVEKLASTEFLDYIKNTKLNVSLLRQLKTTLLTLQVVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + AV WLDDLKDA
Sbjct: 63 INNPAVKLWLDDLKDA 78
>Medtr4g050410.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr4:17853718-17848814 | 20130731
Length = 1268
Score = 84.7 bits (208), Expect = 2e-17, Method: Composition-based stats.
Identities = 42/76 (55%), Positives = 55/76 (72%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +V AFLSA I+ + DKL+S EF +FIR K + + L+ LK TL++++AVL DAEQKQ
Sbjct: 3 ATLVAGAFLSATIQTIADKLSSSEFRSFIRSTKFNYSQLKELKTTLFSLQAVLVDAEQKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
D V +WLDDLKDA
Sbjct: 63 FNDLPVKQWLDDLKDA 78
>Medtr3g033110.1 | NB-ARC domain disease resistance protein,
putative | LC | chr3:10516784-10521691 | 20130731
Length = 1248
Score = 84.7 bits (208), Expect = 2e-17, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 54/76 (71%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AA+VG AFLSA I+ + +KL S EF FI+ K + + L LK TL+A++AVL DAEQKQ
Sbjct: 3 AALVGGAFLSATIQTIAEKLTSSEFRGFIKNTKFNYSQLAELKTTLFALQAVLVDAEQKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
D V +WLDDLKDA
Sbjct: 63 FNDLPVKQWLDDLKDA 78
>Medtr3g032150.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:10088166-10092974 | 20130731
Length = 1280
Score = 84.0 bits (206), Expect = 3e-17, Method: Composition-based stats.
Identities = 40/75 (53%), Positives = 57/75 (76%)
Query: 3 AVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQI 62
A +G AFLSA I+ +++KLAS EF ++I+ KL+ +L ++LK TL ++ VL+DAE+KQI
Sbjct: 2 AAIGSAFLSATIQTLVEKLASTEFRDYIKNTKLNVSLSRQLKTTLLTLQVVLDDAEEKQI 61
Query: 63 KDSAVNKWLDDLKDA 77
+ AV WLDDLKDA
Sbjct: 62 NNPAVKLWLDDLKDA 76
>Medtr3g007190.1 | NB-ARC domain disease resistance protein | LC |
chr3:912445-908911 | 20130731
Length = 1069
Score = 84.0 bits (206), Expect = 3e-17, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 65/76 (85%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V EAFLSAF+EV+++K+ S EF+NF R KKLD +LL++LK TL +++++LNDAE+K
Sbjct: 1 MATIVAEAFLSAFVEVLLEKMISHEFMNFFRCKKLDVSLLEKLKTTLLSLQSILNDAEEK 60
Query: 61 QIKDSAVNKWLDDLKD 76
QI++ AV +WL++L+D
Sbjct: 61 QIRNHAVKQWLENLRD 76
>Medtr3g014510.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:4129087-4133089 | 20130731
Length = 1319
Score = 84.0 bits (206), Expect = 3e-17, Method: Composition-based stats.
Identities = 40/77 (51%), Positives = 59/77 (76%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +VGEA L+A +EV+++K+ S EFV+ R KLD LL++LK T+ +++AVL+DAE+K
Sbjct: 1 MATIVGEALLAASLEVLMEKIVSGEFVDLFRSTKLDVALLEKLKITMLSLQAVLHDAEEK 60
Query: 61 QIKDSAVNKWLDDLKDA 77
QI + AV +WL+ L DA
Sbjct: 61 QITNPAVKQWLEMLHDA 77
>Medtr3g033080.1 | NBS-LRR type disease resistance protein | LC |
chr3:10499898-10504855 | 20130731
Length = 960
Score = 83.6 bits (205), Expect = 4e-17, Method: Composition-based stats.
Identities = 43/75 (57%), Positives = 55/75 (73%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AA+VG AFLSA I+ + +KL+S EF FI+ K + +LL LK TL+A++AVL DAEQKQ
Sbjct: 3 AALVGGAFLSATIQTIAEKLSSSEFRVFIKNTKFNYSLLADLKTTLFALQAVLVDAEQKQ 62
Query: 62 IKDSAVNKWLDDLKD 76
D V +WLDDLKD
Sbjct: 63 FTDLPVKQWLDDLKD 77
>Medtr3g014470.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:4115987-4113349 | 20130731
Length = 829
Score = 83.2 bits (204), Expect = 5e-17, Method: Composition-based stats.
Identities = 41/77 (53%), Positives = 59/77 (76%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA VVGEA LSA +++++ K+ S EF++F KLD LL++LK TL +++AVLNDAE+K
Sbjct: 1 MATVVGEALLSASVKLLLQKMVSSEFIDFFWSMKLDVALLEKLKITLLSLQAVLNDAEEK 60
Query: 61 QIKDSAVNKWLDDLKDA 77
QI + AV +WL+ L+DA
Sbjct: 61 QITNPAVKEWLNMLQDA 77
>Medtr3g019040.1 | disease resistance protein (CC-NBS-LRR class)
family protein | LC | chr3:5299922-5296268 | 20130731
Length = 1150
Score = 81.3 bits (199), Expect = 2e-16, Method: Composition-based stats.
Identities = 39/75 (52%), Positives = 55/75 (73%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +VG AFLS+F +V ++KL+S +F+++ R KLDD LLQ+L+ TL ++ VL +AE K
Sbjct: 1 MAELVGGAFLSSFFQVALEKLSSNDFIDYFRRGKLDDKLLQKLQVTLNSINHVLEEAETK 60
Query: 61 QIKDSAVNKWLDDLK 75
Q + S V KWL DLK
Sbjct: 61 QYQSSYVKKWLGDLK 75
>Medtr8g030860.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr8:11484273-11488844 | 20130731
Length = 1220
Score = 80.9 bits (198), Expect = 3e-16, Method: Composition-based stats.
Identities = 37/76 (48%), Positives = 57/76 (75%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AA++G AFLSA ++ ++DKL S EF ++I KL+++L++ ++ TL A+E VL+DAE+KQ
Sbjct: 3 AALIGGAFLSASVQTLMDKLTSTEFRDYITKTKLNESLMEEMETTLLALEVVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + +WLD LKDA
Sbjct: 63 ILQPKIKQWLDRLKDA 78
>Medtr3g030960.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:9838156-9842432 | 20130731
Length = 1268
Score = 79.3 bits (194), Expect = 8e-16, Method: Composition-based stats.
Identities = 36/75 (48%), Positives = 59/75 (78%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A ++G AFLSA ++ +++KLAS EF ++I+ KL+ +LL++L+ T+ ++AVL+DAE+KQ
Sbjct: 3 ATMIGGAFLSATVQTLVEKLASTEFRDYIKNTKLNVSLLRQLQATMLNLQAVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKD 76
I + V +WLD+LKD
Sbjct: 63 ISNPHVKQWLDNLKD 77
>Medtr3g030980.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:9849109-9853391 | 20130731
Length = 1315
Score = 79.0 bits (193), Expect = 1e-15, Method: Composition-based stats.
Identities = 36/75 (48%), Positives = 59/75 (78%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A ++G AFLSA ++ +++KLAS EF ++I+ KL+ +LL++L+ T+ ++AVL+DAE+KQ
Sbjct: 3 ATMIGGAFLSATVQTLVEKLASTEFRDYIKNTKLNVSLLRQLQATMLNLQAVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKD 76
I + V +WLD+LKD
Sbjct: 63 ISNPHVKQWLDNLKD 77
>Medtr3g018980.1 | disease resistance protein (CC-NBS-LRR class)
family protein | LC | chr3:5269309-5264759 | 20130731
Length = 1147
Score = 78.6 bits (192), Expect = 1e-15, Method: Composition-based stats.
Identities = 38/75 (50%), Positives = 54/75 (72%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +VG AFLS+F +V ++KL+S +F+++ R KLD NLL++L TL ++ VL +AE K
Sbjct: 1 MAELVGGAFLSSFFQVALEKLSSNDFIDYFRRSKLDVNLLEKLLITLNSINHVLEEAEMK 60
Query: 61 QIKDSAVNKWLDDLK 75
Q + V KWLDDLK
Sbjct: 61 QFQSMYVKKWLDDLK 75
>Medtr3g018980.2 | disease resistance protein (CC-NBS-LRR class)
family protein | LC | chr3:5269309-5264760 | 20130731
Length = 951
Score = 78.2 bits (191), Expect = 2e-15, Method: Composition-based stats.
Identities = 38/75 (50%), Positives = 54/75 (72%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +VG AFLS+F +V ++KL+S +F+++ R KLD NLL++L TL ++ VL +AE K
Sbjct: 1 MAELVGGAFLSSFFQVALEKLSSNDFIDYFRRSKLDVNLLEKLLITLNSINHVLEEAEMK 60
Query: 61 QIKDSAVNKWLDDLK 75
Q + V KWLDDLK
Sbjct: 61 QFQSMYVKKWLDDLK 75
>Medtr3g035940.5 | LRR and NB-ARC domain disease resistance
protein | HC | chr3:13332023-13338690 | 20130731
Length = 1245
Score = 77.0 bits (188), Expect = 4e-15, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 60/76 (78%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ +++KLAS EF ++IR KL+ +LL L+ TL A++AVL+DAEQKQ
Sbjct: 3 ATLVGGAFLSATVQTLVEKLASQEFCDYIRNTKLNSSLLAELETTLLALQAVLDDAEQKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I ++AV +WLD LKDA
Sbjct: 63 ITNTAVKQWLDQLKDA 78
>Medtr3g035940.4 | LRR and NB-ARC domain disease resistance
protein | HC | chr3:13332061-13338696 | 20130731
Length = 1245
Score = 77.0 bits (188), Expect = 4e-15, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 60/76 (78%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ +++KLAS EF ++IR KL+ +LL L+ TL A++AVL+DAEQKQ
Sbjct: 3 ATLVGGAFLSATVQTLVEKLASQEFCDYIRNTKLNSSLLAELETTLLALQAVLDDAEQKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I ++AV +WLD LKDA
Sbjct: 63 ITNTAVKQWLDQLKDA 78
>Medtr3g035940.2 | LRR and NB-ARC domain disease resistance
protein | HC | chr3:13332061-13338685 | 20130731
Length = 1245
Score = 77.0 bits (188), Expect = 4e-15, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 60/76 (78%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ +++KLAS EF ++IR KL+ +LL L+ TL A++AVL+DAEQKQ
Sbjct: 3 ATLVGGAFLSATVQTLVEKLASQEFCDYIRNTKLNSSLLAELETTLLALQAVLDDAEQKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I ++AV +WLD LKDA
Sbjct: 63 ITNTAVKQWLDQLKDA 78
>Medtr3g035940.1 | LRR and NB-ARC domain disease resistance
protein | HC | chr3:13332023-13338690 | 20130731
Length = 1245
Score = 77.0 bits (188), Expect = 4e-15, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 60/76 (78%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ +++KLAS EF ++IR KL+ +LL L+ TL A++AVL+DAEQKQ
Sbjct: 3 ATLVGGAFLSATVQTLVEKLASQEFCDYIRNTKLNSSLLAELETTLLALQAVLDDAEQKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I ++AV +WLD LKDA
Sbjct: 63 ITNTAVKQWLDQLKDA 78
>Medtr3g035940.3 | LRR and NB-ARC domain disease resistance
protein | HC | chr3:13332023-13338696 | 20130731
Length = 1245
Score = 77.0 bits (188), Expect = 4e-15, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 60/76 (78%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ +++KLAS EF ++IR KL+ +LL L+ TL A++AVL+DAEQKQ
Sbjct: 3 ATLVGGAFLSATVQTLVEKLASQEFCDYIRNTKLNSSLLAELETTLLALQAVLDDAEQKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I ++AV +WLD LKDA
Sbjct: 63 ITNTAVKQWLDQLKDA 78
>Medtr3g032500.2 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:10259965-10264750 | 20130731
Length = 1256
Score = 77.0 bits (188), Expect = 4e-15, Method: Composition-based stats.
Identities = 35/76 (46%), Positives = 55/76 (72%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AA+VG AFLSA ++ ++DKL SPEF ++ +L+++L+ ++ +L +E VL+DAE+KQ
Sbjct: 3 AALVGGAFLSASVQTLMDKLTSPEFRDYFTRTELNESLMYEMETSLLTLEVVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + +WLD LKDA
Sbjct: 63 ILKPRIKQWLDRLKDA 78
>Medtr3g032500.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:10259935-10264753 | 20130731
Length = 1256
Score = 77.0 bits (188), Expect = 4e-15, Method: Composition-based stats.
Identities = 35/76 (46%), Positives = 55/76 (72%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AA+VG AFLSA ++ ++DKL SPEF ++ +L+++L+ ++ +L +E VL+DAE+KQ
Sbjct: 3 AALVGGAFLSASVQTLMDKLTSPEFRDYFTRTELNESLMYEMETSLLTLEVVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + +WLD LKDA
Sbjct: 63 ILKPRIKQWLDRLKDA 78
>Medtr3g031940.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:10031361-10036083 | 20130731
Length = 1273
Score = 76.6 bits (187), Expect = 4e-15, Method: Composition-based stats.
Identities = 36/76 (47%), Positives = 55/76 (72%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AA+VG AFLSA ++ ++DKL S EF ++I KL+++L+ ++ +L +E VL+DAE+KQ
Sbjct: 3 AALVGGAFLSATLQTLMDKLTSTEFRDYITKTKLNESLMDEMETSLLTLEVVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + +WLD LKDA
Sbjct: 63 ILKPRIKQWLDRLKDA 78
>Medtr3g034380.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:11131865-11126896 | 20130731
Length = 1251
Score = 76.6 bits (187), Expect = 4e-15, Method: Composition-based stats.
Identities = 43/76 (56%), Positives = 60/76 (78%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ ++DKL S EF +FI KKL+ +LL++L+ TL ++AVL+DAE+KQ
Sbjct: 3 ATLVGGAFLSASVQTMLDKLTSTEFRDFINNKKLNVSLLKQLQTTLLVLQAVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + AV KW+DDLKDA
Sbjct: 63 INNRAVKKWVDDLKDA 78
>Medtr3g032200.1 | LRR and NB-ARC domain disease resistance
protein, putative | LC | chr3:10126122-10130750 |
20130731
Length = 1269
Score = 76.6 bits (187), Expect = 4e-15, Method: Composition-based stats.
Identities = 35/76 (46%), Positives = 55/76 (72%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AA+VG AFLSA ++ ++DKL SPEF ++ +L+++L+ ++ +L +E VL+DAE+KQ
Sbjct: 3 AALVGGAFLSASVQTLMDKLTSPEFRDYFTRTELNESLMYEMETSLLTLEVVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + +WLD LKDA
Sbjct: 63 ILKPRIKQWLDRLKDA 78
>Medtr3g033130.1 | NB-ARC domain disease resistance protein,
putative | LC | chr3:10526729-10532558 | 20130731
Length = 1264
Score = 76.6 bits (187), Expect = 5e-15, Method: Composition-based stats.
Identities = 40/76 (52%), Positives = 51/76 (67%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AA+V A LSA + + DKL+S EF FIR + + + L LK TL+A++AVL DAEQKQ
Sbjct: 3 AALVAGACLSATTQTIADKLSSSEFRGFIRNTRFNYSPLAELKTTLFALQAVLVDAEQKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
D V +WL DLKDA
Sbjct: 63 FTDLPVKQWLHDLKDA 78
>Medtr0002s0090.1 | LRR and NB-ARC domain disease resistance
protein | HC | scaffold0002:136587-131385 | 20130731
Length = 1244
Score = 76.6 bits (187), Expect = 5e-15, Method: Composition-based stats.
Identities = 42/76 (55%), Positives = 60/76 (78%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ +++KLAS EF ++IR KL+ +LL L+ TL A++AVL+DAEQKQ
Sbjct: 3 ATLVGGAFLSATVQTLVEKLASQEFCDYIRNTKLNSSLLAELETTLLALQAVLDDAEQKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I ++AV +W+D LKDA
Sbjct: 63 ITNTAVKQWMDQLKDA 78
>Medtr3g035500.1 | LRR and NB-ARC domain disease resistance
protein | HC | chr3:13170358-13174135 | 20130731
Length = 1244
Score = 76.6 bits (187), Expect = 5e-15, Method: Composition-based stats.
Identities = 42/76 (55%), Positives = 60/76 (78%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ +++KLAS EF ++IR KL+ +LL L+ TL A++AVL+DAEQKQ
Sbjct: 3 ATLVGGAFLSATVQTLVEKLASQEFCDYIRNTKLNSSLLAELETTLLALQAVLDDAEQKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I ++AV +W+D LKDA
Sbjct: 63 ITNTAVKQWMDQLKDA 78
>Medtr3g033380.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:10662695-10668328 | 20130731
Length = 1276
Score = 76.6 bits (187), Expect = 5e-15, Method: Composition-based stats.
Identities = 35/76 (46%), Positives = 55/76 (72%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AA+VG AFLSA ++ ++DKL SPEF ++ +L+++L+ ++ +L +E VL+DAE+KQ
Sbjct: 3 AALVGGAFLSASVQTLMDKLTSPEFRDYFTRTELNESLMYEMETSLLTLEVVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + +WLD LKDA
Sbjct: 63 ILKPRIKQWLDRLKDA 78
>Medtr3g032110.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:10076401-10082397 | 20130731
Length = 1288
Score = 75.9 bits (185), Expect = 8e-15, Method: Composition-based stats.
Identities = 33/76 (43%), Positives = 57/76 (75%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A ++G AFL A ++ +++KL S EF+++I+ L+ +L ++L+ T+ ++AVL+DAE+KQ
Sbjct: 3 ATMIGGAFLHATVQTLVEKLTSTEFLDYIKNTNLNVSLFRQLQTTMLNLQAVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + V +WLD+LKDA
Sbjct: 63 ISNPHVRQWLDNLKDA 78
>Medtr3g018930.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:5251491-5247151 | 20130731
Length = 1156
Score = 75.9 bits (185), Expect = 8e-15, Method: Composition-based stats.
Identities = 37/75 (49%), Positives = 53/75 (70%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
M +VG AFLS+F +V ++KL+S +F+++ R KLD NLL++L TL ++ VL +AE K
Sbjct: 3 MRELVGGAFLSSFFQVALEKLSSNDFIDYFRRSKLDVNLLEKLLITLNSINHVLEEAEMK 62
Query: 61 QIKDSAVNKWLDDLK 75
Q + V KWLDDLK
Sbjct: 63 QYQSMYVKKWLDDLK 77
>Medtr3g033860.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:10888618-10892434 | 20130731
Length = 1252
Score = 75.5 bits (184), Expect = 9e-15, Method: Composition-based stats.
Identities = 42/76 (55%), Positives = 60/76 (78%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ ++D+L S EF +FI KKL+ +LL++L+ TL ++AVL+DAE+KQ
Sbjct: 3 ATLVGGAFLSASVQTMLDQLTSTEFRDFINNKKLNVSLLKQLQTTLLVLQAVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + AV +WLDDLKDA
Sbjct: 63 INNRAVKQWLDDLKDA 78
>Medtr3g018930.2 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:5251494-5247151 | 20130731
Length = 799
Score = 75.5 bits (184), Expect = 1e-14, Method: Composition-based stats.
Identities = 37/75 (49%), Positives = 53/75 (70%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
M +VG AFLS+F +V ++KL+S +F+++ R KLD NLL++L TL ++ VL +AE K
Sbjct: 3 MRELVGGAFLSSFFQVALEKLSSNDFIDYFRRSKLDVNLLEKLLITLNSINHVLEEAEMK 62
Query: 61 QIKDSAVNKWLDDLK 75
Q + V KWLDDLK
Sbjct: 63 QYQSMYVKKWLDDLK 77
>Medtr8g038590.1 | NBS-LRR type disease resistance protein | HC |
chr8:14310401-14314587 | 20130731
Length = 1252
Score = 75.1 bits (183), Expect = 1e-14, Method: Composition-based stats.
Identities = 37/73 (50%), Positives = 53/73 (72%)
Query: 5 VGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIKD 64
VG A LSAF++V +KLAS E ++ R KL+ NLL++L TL +++AV++DAE KQI++
Sbjct: 6 VGGALLSAFLQVTFEKLASAEIGDYFRRTKLNHNLLKKLNITLLSIDAVVDDAELKQIRN 65
Query: 65 SAVNKWLDDLKDA 77
V WLD +KDA
Sbjct: 66 PNVRAWLDAVKDA 78
>Medtr8g038570.1 | NBS-LRR type disease resistance protein | HC |
chr8:14295440-14299792 | 20130731
Length = 1245
Score = 75.1 bits (183), Expect = 1e-14, Method: Composition-based stats.
Identities = 32/72 (44%), Positives = 51/72 (70%)
Query: 5 VGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIKD 64
+G A LSA ++V D+LASPE V++ +G+K ++ LL++L ++ V++DAEQKQI++
Sbjct: 6 IGSALLSASLQVAFDRLASPEVVDYFQGRKFNEKLLKKLNIMFLSINVVIDDAEQKQIRN 65
Query: 65 SAVNKWLDDLKD 76
V WLD +KD
Sbjct: 66 QQVKAWLDAVKD 77
>Medtr3g014040.1 | LRR and NB-ARC domain disease resistance
protein | HC | chr3:3884543-3888294 | 20130731
Length = 1216
Score = 74.3 bits (181), Expect = 2e-14, Method: Composition-based stats.
Identities = 43/73 (58%), Positives = 60/73 (82%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AA VGEAFLSA +EV+++K+ S EF+NF K+LD +LL++LK TL +++AVLNDAE+KQ
Sbjct: 3 AAFVGEAFLSASVEVLLNKIVSNEFLNFFHSKELDVSLLKKLKITLLSLQAVLNDAEEKQ 62
Query: 62 IKDSAVNKWLDDL 74
I + AV +WLD+L
Sbjct: 63 ITNPAVKEWLDEL 75
>Medtr3g033160.1 | hypothetical protein | LC |
chr3:10539695-10541622 | 20130731
Length = 121
Score = 73.9 bits (180), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 38/70 (54%), Positives = 49/70 (70%)
Query: 8 AFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIKDSAV 67
A LSA + + DKL+S EF FIR + + +LL LK TL+A+++VL DAEQKQ D V
Sbjct: 38 ACLSATTQTIADKLSSSEFRGFIRNTRFNYSLLAELKTTLFALQSVLVDAEQKQFIDLPV 97
Query: 68 NKWLDDLKDA 77
+WLDDLKDA
Sbjct: 98 KQWLDDLKDA 107
>Medtr3g034430.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:11149620-11144660 | 20130731
Length = 1276
Score = 73.6 bits (179), Expect = 4e-14, Method: Composition-based stats.
Identities = 41/76 (53%), Positives = 60/76 (78%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ ++D+L S EF +FI KKL+ +LL++L+ TL ++AVL+DA++KQ
Sbjct: 3 ATLVGGAFLSASVQSMLDQLTSTEFRDFINNKKLNVSLLKQLQTTLLVLQAVLDDADEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + AV +WLDDLKDA
Sbjct: 63 INNPAVKQWLDDLKDA 78
>Medtr3g014530.1 | CC-NBS-LRR resistance protein, putative | LC |
chr3:4140676-4141276 | 20130731
Length = 159
Score = 73.2 bits (178), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 38/74 (51%), Positives = 57/74 (77%)
Query: 4 VVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIK 63
+V EA L+A EV+++K+ S +FV+F R KLD +LL++ K TL +++AVL+DAE+KQI
Sbjct: 1 MVVEALLAASFEVLLEKIVSGDFVDFFRSTKLDLSLLKKQKITLLSLQAVLHDAEEKQIT 60
Query: 64 DSAVNKWLDDLKDA 77
+ AV +WLD L+DA
Sbjct: 61 NPAVKEWLDMLQDA 74
>Medtr3g014320.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:4061512-4057484 | 20130731
Length = 1342
Score = 72.8 bits (177), Expect = 7e-14, Method: Composition-based stats.
Identities = 40/77 (51%), Positives = 59/77 (76%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V EA LSA +++++ K+ + +FV+FIR KLD LL++L TL +++AVL+DAE+K
Sbjct: 1 MATIVVEALLSATLDLLLKKIVAEDFVDFIRSTKLDVALLEKLNVTLLSLQAVLHDAEEK 60
Query: 61 QIKDSAVNKWLDDLKDA 77
QI + AV KWLD L+DA
Sbjct: 61 QITNPAVKKWLDLLRDA 77
>Medtr3g032340.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:10183454-10189298 | 20130731
Length = 1293
Score = 72.4 bits (176), Expect = 1e-13, Method: Composition-based stats.
Identities = 36/78 (46%), Positives = 56/78 (71%), Gaps = 1/78 (1%)
Query: 1 MAAV-VGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQ 59
MAAV +G AFL+A ++ + DKLAS EF ++I +L+++L+ ++ +L +E VL+DAE+
Sbjct: 1 MAAVLIGGAFLAATLQTLTDKLASIEFRDYITKTELNESLIDEMETSLLTLEVVLDDAEE 60
Query: 60 KQIKDSAVNKWLDDLKDA 77
KQI + +WLD LKDA
Sbjct: 61 KQILKPRIKQWLDRLKDA 78
>Medtr3g014080.1 | LRR and NB-ARC domain disease resistance
protein | HC | chr3:3914596-3909846 | 20130731
Length = 1247
Score = 72.0 bits (175), Expect = 1e-13, Method: Composition-based stats.
Identities = 41/75 (54%), Positives = 60/75 (80%)
Query: 3 AVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQI 62
A VGEAFLSA +EV++D++ E + F R K+LD +LL++LK TL +++AV+NDAE+KQI
Sbjct: 2 AFVGEAFLSASLEVLLDRIIPDELLYFSRNKELDTSLLKKLKITLLSLQAVMNDAEEKQI 61
Query: 63 KDSAVNKWLDDLKDA 77
+ AV +WLD+L+DA
Sbjct: 62 TNPAVKQWLDELRDA 76
>Medtr3g014080.2 | LRR and NB-ARC domain disease resistance
protein | HC | chr3:3914596-3909846 | 20130731
Length = 1212
Score = 72.0 bits (175), Expect = 1e-13, Method: Composition-based stats.
Identities = 41/75 (54%), Positives = 60/75 (80%)
Query: 3 AVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQI 62
A VGEAFLSA +EV++D++ E + F R K+LD +LL++LK TL +++AV+NDAE+KQI
Sbjct: 2 AFVGEAFLSASLEVLLDRIIPDELLYFSRNKELDTSLLKKLKITLLSLQAVMNDAEEKQI 61
Query: 63 KDSAVNKWLDDLKDA 77
+ AV +WLD+L+DA
Sbjct: 62 TNPAVKQWLDELRDA 76
>Medtr0003s0170.1 | NB-ARC domain disease resistance protein | HC
| scaffold0003:101766-100881 | 20130731
Length = 273
Score = 71.2 bits (173), Expect = 2e-13, Method: Composition-based stats.
Identities = 33/70 (47%), Positives = 51/70 (72%)
Query: 8 AFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIKDSAV 67
+F+SA ++V++D++A +F++F RG LD+ LL +LK L +V VLNDAE+KQ D V
Sbjct: 7 SFVSAILQVLLDRIAHRDFIDFFRGNHLDEALLDKLKMFLLSVTTVLNDAEEKQFFDPFV 66
Query: 68 NKWLDDLKDA 77
+W+D LK+A
Sbjct: 67 KEWVDKLKNA 76
>Medtr1g037730.1 | NB-ARC domain disease resistance protein | HC |
chr1:14006153-14004769 | 20130731
Length = 376
Score = 71.2 bits (173), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 43/73 (58%), Positives = 60/73 (82%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
AA VGEAFLSA +EV+++K+ S EF+NF K+LD +LL++LK TL +++AVLNDAE+KQ
Sbjct: 3 AAFVGEAFLSASVEVLLNKIVSKEFLNFFHSKELDVSLLKKLKITLLSLQAVLNDAEEKQ 62
Query: 62 IKDSAVNKWLDDL 74
I + AV +WLD+L
Sbjct: 63 ITNPAVKEWLDEL 75
>Medtr1g047800.1 | disease resistance protein (CC-NBS-LRR class)
family protein | HC | chr1:18084465-18087983 | 20130731
Length = 1083
Score = 71.2 bits (173), Expect = 2e-13, Method: Composition-based stats.
Identities = 35/73 (47%), Positives = 51/73 (69%), Gaps = 1/73 (1%)
Query: 4 VVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIK 63
+V + A V+ +++AS E NF + KK +NLL+RLK L +V AVLNDAE+KQ+K
Sbjct: 5 LVAGPLMGAVFNVLFERIASSEVANFFKKKK-SENLLKRLKIMLLSVHAVLNDAEEKQMK 63
Query: 64 DSAVNKWLDDLKD 76
+ AV +WL++LKD
Sbjct: 64 NEAVKEWLEELKD 76
>Medtr2g039090.1 | NBS-LRR type disease resistance protein | LC |
chr2:17106458-17111291 | 20130731
Length = 1229
Score = 70.9 bits (172), Expect = 3e-13, Method: Composition-based stats.
Identities = 35/76 (46%), Positives = 54/76 (71%), Gaps = 1/76 (1%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A VG A +++ I+V++DKLAS E +++ R KLD NLL +L N+L ++ AV+ AEQ+Q
Sbjct: 3 AEFVGGAIVNSIIQVLVDKLASTEMMDYFR-TKLDGNLLMKLNNSLISINAVVEYAEQQQ 61
Query: 62 IKDSAVNKWLDDLKDA 77
I+ S V W+ ++KDA
Sbjct: 62 IRRSTVRTWICNVKDA 77
>Medtr3g019000.2 | disease resistance protein (CC-NBS-LRR class)
family protein | LC | chr3:5283119-5277655 | 20130731
Length = 1151
Score = 70.5 bits (171), Expect = 4e-13, Method: Composition-based stats.
Identities = 36/77 (46%), Positives = 51/77 (66%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MAA V AF+S+F+E+++++LAS +F + KLD L +L TL ++ VL +AEQ
Sbjct: 1 MAATVAGAFISSFVEMILERLASGDFRDNFSRYKLDVGLADKLGITLNSINQVLEEAEQM 60
Query: 61 QIKDSAVNKWLDDLKDA 77
Q K + V KWLDDLK A
Sbjct: 61 QYKSTYVKKWLDDLKHA 77
>Medtr3g019000.1 | disease resistance protein (CC-NBS-LRR class)
family protein | LC | chr3:5283058-5278220 | 20130731
Length = 1151
Score = 70.5 bits (171), Expect = 4e-13, Method: Composition-based stats.
Identities = 36/77 (46%), Positives = 51/77 (66%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MAA V AF+S+F+E+++++LAS +F + KLD L +L TL ++ VL +AEQ
Sbjct: 1 MAATVAGAFISSFVEMILERLASGDFRDNFSRYKLDVGLADKLGITLNSINQVLEEAEQM 60
Query: 61 QIKDSAVNKWLDDLKDA 77
Q K + V KWLDDLK A
Sbjct: 61 QYKSTYVKKWLDDLKHA 77
>Medtr3g035480.1 | LRR and NB-ARC domain disease resistance
protein | HC | chr3:13160298-13165582 | 20130731
Length = 1301
Score = 70.5 bits (171), Expect = 4e-13, Method: Composition-based stats.
Identities = 40/76 (52%), Positives = 57/76 (75%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ ++ KLAS EF ++IR KL+ +LL L+ TL A++ VL+DAE KQ
Sbjct: 3 ATLVGGAFLSATVQTLVAKLASQEFCDYIRNTKLNSSLLAELETTLLALQVVLDDAELKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I ++AV +W+D LKDA
Sbjct: 63 ITNTAVKQWMDQLKDA 78
>Medtr0002s0110.1 | LRR and NB-ARC domain disease resistance
protein | HC | scaffold0002:146638-142901 | 20130731
Length = 1245
Score = 70.1 bits (170), Expect = 4e-13, Method: Composition-based stats.
Identities = 40/76 (52%), Positives = 57/76 (75%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ ++ KLAS EF ++IR KL+ +LL L+ TL A++ VL+DAE KQ
Sbjct: 3 ATLVGGAFLSATVQTLVAKLASQEFCDYIRNTKLNSSLLAELETTLLALQVVLDDAELKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I ++AV +W+D LKDA
Sbjct: 63 ITNTAVKQWMDQLKDA 78
>Medtr3g035840.1 | NB-ARC domain disease resistance protein | HC |
chr3:13288800-13292283 | 20130731
Length = 540
Score = 69.7 bits (169), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 41/76 (53%), Positives = 58/76 (76%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ +++KLAS EF ++IR KL+ +LL L+ TL A++ VL+DAE KQ
Sbjct: 3 ATLVGGAFLSATVQTLVEKLASQEFCDYIRNNKLNSSLLAELETTLLALQVVLDDAELKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I ++AV +WLD LKDA
Sbjct: 63 ITNTAVKQWLDQLKDA 78
>Medtr3g035840.2 | NB-ARC domain disease resistance protein | HC |
chr3:13288800-13292283 | 20130731
Length = 540
Score = 69.7 bits (169), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 41/76 (53%), Positives = 58/76 (76%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A +VG AFLSA ++ +++KLAS EF ++IR KL+ +LL L+ TL A++ VL+DAE KQ
Sbjct: 3 ATLVGGAFLSATVQTLVEKLASQEFCDYIRNNKLNSSLLAELETTLLALQVVLDDAELKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I ++AV +WLD LKDA
Sbjct: 63 ITNTAVKQWLDQLKDA 78
>Medtr3g032760.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:10364497-10360691 | 20130731
Length = 1268
Score = 68.9 bits (167), Expect = 1e-12, Method: Composition-based stats.
Identities = 39/76 (51%), Positives = 61/76 (80%)
Query: 2 AAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQ 61
A ++G AFLSA ++ +++KLAS EF+++I+ KL+D+LL++L+ TL ++ VL+DAE+KQ
Sbjct: 3 ATMIGGAFLSATVQTLVEKLASTEFLDYIKNTKLNDSLLRQLQTTLLTLQVVLDDAEEKQ 62
Query: 62 IKDSAVNKWLDDLKDA 77
I + AV +WLD LKDA
Sbjct: 63 INNPAVKQWLDGLKDA 78
>Medtr0005s0200.1 | NBS-LRR type disease resistance protein | HC |
scaffold0005:283659-288410 | 20130731
Length = 1155
Score = 67.0 bits (162), Expect = 3e-12, Method: Composition-based stats.
Identities = 35/70 (50%), Positives = 51/70 (72%)
Query: 8 AFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIKDSAV 67
A LSA ++V++D++A P+F++F RG LD+ LL +LK L +V VLNDAE+KQ D V
Sbjct: 27 AHLSAILQVLLDRIAHPDFIDFFRGNHLDETLLDKLKMLLLSVTIVLNDAEEKQFFDPFV 86
Query: 68 NKWLDDLKDA 77
+W+D LK+A
Sbjct: 87 KEWVDKLKNA 96
>Medtr1g037610.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr1:13932514-13938028 | 20130731
Length = 1503
Score = 67.0 bits (162), Expect = 4e-12, Method: Composition-based stats.
Identities = 40/77 (51%), Positives = 59/77 (76%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V EA LSA +E+++ K+ + +FV+FIR KLD LL++L TL +++AVL+DAE+K
Sbjct: 1 MATIVVEALLSASLELLLKKIVAEDFVDFIRSTKLDVALLEKLNVTLLSLQAVLHDAEEK 60
Query: 61 QIKDSAVNKWLDDLKDA 77
QI + AV +WLD L+DA
Sbjct: 61 QITNPAVKQWLDLLRDA 77
>Medtr3g015260.1 | disease resistance protein (CC-NBS-LRR class)
family protein | LC | chr3:4387847-4391292 | 20130731
Length = 1114
Score = 66.2 bits (160), Expect = 6e-12, Method: Composition-based stats.
Identities = 39/75 (52%), Positives = 56/75 (74%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +VG AFLS+F +V ++KL+S +F+++ RG KLDD LL++L TL ++ VL +AE K
Sbjct: 3 MAELVGGAFLSSFFQVALEKLSSNDFIDYFRGSKLDDKLLEKLLITLNSINRVLEEAEMK 62
Query: 61 QIKDSAVNKWLDDLK 75
Q + +V KWLDDLK
Sbjct: 63 QYQSMSVKKWLDDLK 77
>Medtr3g015260.2 | disease resistance protein (CC-NBS-LRR class)
family protein | LC | chr3:4387762-4391753 | 20130731
Length = 1012
Score = 66.2 bits (160), Expect = 7e-12, Method: Composition-based stats.
Identities = 39/75 (52%), Positives = 56/75 (74%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +VG AFLS+F +V ++KL+S +F+++ RG KLDD LL++L TL ++ VL +AE K
Sbjct: 3 MAELVGGAFLSSFFQVALEKLSSNDFIDYFRGSKLDDKLLEKLLITLNSINRVLEEAEMK 62
Query: 61 QIKDSAVNKWLDDLK 75
Q + +V KWLDDLK
Sbjct: 63 QYQSMSVKKWLDDLK 77
>Medtr7g078790.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr7:29835955-29839677 | 20130731
Length = 910
Score = 65.9 bits (159), Expect = 8e-12, Method: Composition-based stats.
Identities = 40/72 (55%), Positives = 54/72 (75%)
Query: 6 GEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIKDS 65
G AFLSA I ++DKL S EF +++ KL+ +LL++L+ TL +EAVL DAE+KQI D
Sbjct: 5 GGAFLSAPILTMMDKLTSTEFQDYVNNMKLNHSLLKQLQTTLLTLEAVLVDAERKQIHDP 64
Query: 66 AVNKWLDDLKDA 77
AV +WL+DLKDA
Sbjct: 65 AVREWLNDLKDA 76
>Medtr3g014500.1 | NB-ARC domain disease resistance protein,
putative | HC | chr3:4123569-4124231 | 20130731
Length = 179
Score = 65.9 bits (159), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 31/76 (40%), Positives = 56/76 (73%)
Query: 3 AVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQI 62
+++G A ++A +++++DK+ + EF++F++ KLD LL++LK TL +++AVL+DAE KQI
Sbjct: 5 SLLGGALIAASVKILLDKIVAGEFIDFVQSWKLDVTLLEKLKITLLSLQAVLHDAEDKQI 64
Query: 63 KDSAVNKWLDDLKDAC 78
+ V +WL L+ A
Sbjct: 65 TNPNVKEWLHRLQGAV 80
>Medtr5g037590.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr5:16446049-16449609 | 20130731
Length = 1186
Score = 60.1 bits (144), Expect = 4e-10, Method: Composition-based stats.
Identities = 31/60 (51%), Positives = 41/60 (68%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MAA+VGE +S +EV+++KL S EFV+ R KLDD+LL +LK TL +E VL E K
Sbjct: 1 MAAIVGEKMISNSVEVLLEKLVSGEFVDDFRSTKLDDSLLTKLKKTLMTIEYVLYIDENK 60
>Medtr1g008240.1 | NB-ARC domain disease resistance protein | LC |
chr1:825317-829126 | 20130731
Length = 1269
Score = 56.6 bits (135), Expect = 5e-09, Method: Composition-based stats.
Identities = 29/74 (39%), Positives = 48/74 (64%)
Query: 4 VVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIK 63
+V AFLSA +E ++ KLAS EF ++I+ +L+ L TL + +VL+DAEQKQ
Sbjct: 1 MVEGAFLSATVESLLHKLASSEFTDYIKYSELNILKLTVFVTTLLTLRSVLHDAEQKQFF 60
Query: 64 DSAVNKWLDDLKDA 77
+ + +W+++L +A
Sbjct: 61 NPKIKQWMNELYNA 74
>Medtr3g022600.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:6737109-6733309 | 20130731
Length = 1266
Score = 56.2 bits (134), Expect = 6e-09, Method: Composition-based stats.
Identities = 30/75 (40%), Positives = 47/75 (62%), Gaps = 1/75 (1%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V AFL + +V+I+KLAS + ++ +D L + L N L ++ VL++AE K
Sbjct: 1 MAELVAGAFLQSSFQVIIEKLASVDIRDYFSSNNVD-ALAKELNNALDSINQVLDEAEIK 59
Query: 61 QIKDSAVNKWLDDLK 75
Q ++ V KWLD+LK
Sbjct: 60 QYQNKYVKKWLDELK 74
>Medtr3g025360.1 | NB-ARC domain disease resistance protein,
putative | LC | chr3:7751170-7747769 | 20130731
Length = 1133
Score = 55.8 bits (133), Expect = 9e-09, Method: Composition-based stats.
Identities = 30/75 (40%), Positives = 48/75 (64%), Gaps = 5/75 (6%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA VVG AFLS+ +V+ ++LAS +F ++ + L ++L+ TL ++ VL+DA+ K
Sbjct: 1 MAGVVGGAFLSSVFQVIRERLASQDFRDYFH-----ERLWKKLEITLDSINEVLDDADIK 55
Query: 61 QIKDSAVNKWLDDLK 75
+ + V WLDDLK
Sbjct: 56 EYQHRNVKNWLDDLK 70
>Medtr3g022790.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:6837798-6841893 | 20130731
Length = 1351
Score = 55.8 bits (133), Expect = 1e-08, Method: Composition-based stats.
Identities = 28/75 (37%), Positives = 48/75 (64%), Gaps = 5/75 (6%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +VG A LS+F V++ ++ S +F + K L+++L+ TL +++ +LNDAE K
Sbjct: 1 MAELVGGAVLSSFFPVILKRIGSRDFKDLFNKK-----LVEKLEVTLNSIDQLLNDAETK 55
Query: 61 QIKDSAVNKWLDDLK 75
+ ++ V KW D+LK
Sbjct: 56 KYQNQNVKKWFDNLK 70
>Medtr2g038760.1 | NBS-LRR type disease resistance protein | LC |
chr2:16974548-16978812 | 20130731
Length = 1254
Score = 55.8 bits (133), Expect = 1e-08, Method: Composition-based stats.
Identities = 30/73 (41%), Positives = 44/73 (60%), Gaps = 8/73 (10%)
Query: 5 VGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIKD 64
+G A S+F E +IDKL+S E +D+NL RL L+++ AV +DAE+KQI +
Sbjct: 17 LGGAIASSFFEALIDKLSSAE--------TIDENLHSRLITALFSINAVADDAEKKQINN 68
Query: 65 SAVNKWLDDLKDA 77
V +WL +KD
Sbjct: 69 FHVKEWLLGVKDG 81
>Medtr3g021100.2 | disease resistance protein (CC-NBS-LRR class)
family protein | LC | chr3:6143391-6139939 | 20130731
Length = 1150
Score = 53.9 bits (128), Expect = 3e-08, Method: Composition-based stats.
Identities = 29/75 (38%), Positives = 47/75 (62%), Gaps = 6/75 (8%)
Query: 1 MAAV-VGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQ 59
MA V VG AFLS I+++ +KL S +F ++ + L+++L+ TL ++ VL+D E
Sbjct: 1 MAEVDVGRAFLSPVIQLICEKLTSTDFRDYFH-----EGLVKKLEITLKSINYVLDDTET 55
Query: 60 KQIKDSAVNKWLDDL 74
KQ ++ V WLDD+
Sbjct: 56 KQYQNQTVKNWLDDV 70
>Medtr3g021100.1 | disease resistance protein (CC-NBS-LRR class)
family protein | LC | chr3:6143391-6139939 | 20130731
Length = 1150
Score = 53.9 bits (128), Expect = 3e-08, Method: Composition-based stats.
Identities = 29/75 (38%), Positives = 47/75 (62%), Gaps = 6/75 (8%)
Query: 1 MAAV-VGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQ 59
MA V VG AFLS I+++ +KL S +F ++ + L+++L+ TL ++ VL+D E
Sbjct: 1 MAEVDVGRAFLSPVIQLICEKLTSTDFRDYFH-----EGLVKKLEITLKSINYVLDDTET 55
Query: 60 KQIKDSAVNKWLDDL 74
KQ ++ V WLDD+
Sbjct: 56 KQYQNQTVKNWLDDV 70
>Medtr3g027250.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:8473681-8469055 | 20130731
Length = 1165
Score = 53.5 bits (127), Expect = 4e-08, Method: Composition-based stats.
Identities = 28/75 (37%), Positives = 47/75 (62%), Gaps = 5/75 (6%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA ++G AFLS+F +V + +AS +F + K L+++L+ TL ++ +L+DAE K
Sbjct: 1 MAELIGGAFLSSFFQVTLQSIASRDFKDLCNKK-----LVKKLEITLNSINQLLDDAETK 55
Query: 61 QIKDSAVNKWLDDLK 75
+ ++ V WLD LK
Sbjct: 56 KYQNQNVKNWLDRLK 70
>Medtr3g027250.2 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:8473760-8469055 | 20130731
Length = 1165
Score = 53.5 bits (127), Expect = 4e-08, Method: Composition-based stats.
Identities = 28/75 (37%), Positives = 47/75 (62%), Gaps = 5/75 (6%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA ++G AFLS+F +V + +AS +F + K L+++L+ TL ++ +L+DAE K
Sbjct: 1 MAELIGGAFLSSFFQVTLQSIASRDFKDLCNKK-----LVKKLEITLNSINQLLDDAETK 55
Query: 61 QIKDSAVNKWLDDLK 75
+ ++ V WLD LK
Sbjct: 56 KYQNQNVKNWLDRLK 70
>Medtr3g027250.3 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:8473777-8469055 | 20130731
Length = 1165
Score = 53.5 bits (127), Expect = 4e-08, Method: Composition-based stats.
Identities = 28/75 (37%), Positives = 47/75 (62%), Gaps = 5/75 (6%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA ++G AFLS+F +V + +AS +F + K L+++L+ TL ++ +L+DAE K
Sbjct: 1 MAELIGGAFLSSFFQVTLQSIASRDFKDLCNKK-----LVKKLEITLNSINQLLDDAETK 55
Query: 61 QIKDSAVNKWLDDLK 75
+ ++ V WLD LK
Sbjct: 56 KYQNQNVKNWLDRLK 70
>Medtr3g035810.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:13269411-13274142 | 20130731
Length = 986
Score = 53.5 bits (127), Expect = 4e-08, Method: Composition-based stats.
Identities = 29/77 (37%), Positives = 49/77 (63%), Gaps = 6/77 (7%)
Query: 1 MAAV-VGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQ 59
MA V VG+AFLS I+++ +KL S F ++ + L+++L+ TL ++ +L+DAE
Sbjct: 1 MAEVDVGQAFLSPIIQLICEKLTSTYFRDYFH-----EGLVKKLEITLKSINYLLDDAET 55
Query: 60 KQIKDSAVNKWLDDLKD 76
KQ ++ V WLDD+ +
Sbjct: 56 KQYQNQRVENWLDDVSN 72
>Medtr0425s0020.1 | LRR and NB-ARC domain disease resistance
protein | LC | scaffold0425:6387-10157 | 20130731
Length = 1256
Score = 53.5 bits (127), Expect = 5e-08, Method: Composition-based stats.
Identities = 29/75 (38%), Positives = 47/75 (62%), Gaps = 1/75 (1%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V AFL + +V+I+KLAS ++ +D+ L++ L L ++ VL++AE K
Sbjct: 1 MAELVAGAFLQSSFQVIIEKLASVGIRDYFSSNNVDE-LVKELNIALDSINQVLDEAEIK 59
Query: 61 QIKDSAVNKWLDDLK 75
Q ++ V KWLD+LK
Sbjct: 60 QYQNKYVKKWLDELK 74
>Medtr0425s0020.2 | LRR and NB-ARC domain disease resistance
protein | LC | scaffold0425:6387-10157 | 20130731
Length = 1256
Score = 53.5 bits (127), Expect = 5e-08, Method: Composition-based stats.
Identities = 29/75 (38%), Positives = 47/75 (62%), Gaps = 1/75 (1%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V AFL + +V+I+KLAS ++ +D+ L++ L L ++ VL++AE K
Sbjct: 1 MAELVAGAFLQSSFQVIIEKLASVGIRDYFSSNNVDE-LVKELNIALDSINQVLDEAEIK 59
Query: 61 QIKDSAVNKWLDDLK 75
Q ++ V KWLD+LK
Sbjct: 60 QYQNKYVKKWLDELK 74
>Medtr3g022300.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:6551744-6557109 | 20130731
Length = 1223
Score = 53.1 bits (126), Expect = 5e-08, Method: Composition-based stats.
Identities = 29/75 (38%), Positives = 47/75 (62%), Gaps = 1/75 (1%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V AFL + +V+I+KLAS ++ +D+ L++ L L ++ VL++AE K
Sbjct: 1 MAELVAGAFLQSSFQVIIEKLASVGIRDYFSSNNVDE-LVKELNIALDSINQVLDEAEIK 59
Query: 61 QIKDSAVNKWLDDLK 75
Q ++ V KWLD+LK
Sbjct: 60 QYQNKYVKKWLDELK 74
>Medtr2g039040.1 | NBS-LRR type disease resistance protein | LC |
chr2:17093134-17094904 | 20130731
Length = 578
Score = 53.1 bits (126), Expect = 6e-08, Method: Composition-based stats.
Identities = 29/72 (40%), Positives = 42/72 (58%), Gaps = 8/72 (11%)
Query: 6 GEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIKDS 65
G A S+F E +IDKL+S E +D+NL RL L+++ V +DAE+KQI +
Sbjct: 7 GGAIASSFFEALIDKLSSAE--------TMDENLHSRLITALFSINVVADDAEKKQIDNF 58
Query: 66 AVNKWLDDLKDA 77
V +WL +KD
Sbjct: 59 HVKEWLLGVKDG 70
>Medtr1g045960.1 | NB-ARC domain disease resistance protein | LC |
chr1:17310973-17314581 | 20130731
Length = 1202
Score = 52.8 bits (125), Expect = 6e-08, Method: Composition-based stats.
Identities = 31/77 (40%), Positives = 45/77 (58%), Gaps = 6/77 (7%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
M +V E LS ++V+++K+ S EFV+ R KLD +LL+ LK L + E V+ND
Sbjct: 1 MEGIVLETLLSTCVKVMLNKIVSSEFVDNYRRTKLDVSLLENLKTELLSFEVVVND---- 56
Query: 61 QIKDSAVNKWLDDLKDA 77
+VN WL+ L DA
Sbjct: 57 --DAVSVNVWLNMLSDA 71
>Medtr3g023030.3 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:6950560-6944672 | 20130731
Length = 1125
Score = 52.8 bits (125), Expect = 7e-08, Method: Composition-based stats.
Identities = 31/77 (40%), Positives = 48/77 (62%), Gaps = 3/77 (3%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V AFL + +V+I+KLAS ++ +DD L++ L + L ++ VL++AE K
Sbjct: 1 MAELVAGAFLQSSFQVIIEKLASVGIRDYFSSNNVDD-LVKELHSALDSINLVLDEAEIK 59
Query: 61 QIKDSAVN--KWLDDLK 75
Q + VN KWLD+LK
Sbjct: 60 QYQKKYVNVKKWLDELK 76
>Medtr3g022940.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:6918182-6914754 | 20130731
Length = 1142
Score = 52.8 bits (125), Expect = 7e-08, Method: Composition-based stats.
Identities = 28/72 (38%), Positives = 45/72 (62%), Gaps = 5/72 (6%)
Query: 4 VVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIK 63
+ G+AFLS +V+ ++L+S F ++ DD L++ + TL ++ VL+DAE KQ +
Sbjct: 1 MAGKAFLSYVFQVIHERLSSSYFRDY-----FDDGLVKIFEITLDSINEVLDDAEVKQYQ 55
Query: 64 DSAVNKWLDDLK 75
+ V WLDDLK
Sbjct: 56 NRDVKNWLDDLK 67
>Medtr3g022130.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:6478892-6484534 | 20130731
Length = 1107
Score = 52.8 bits (125), Expect = 7e-08, Method: Composition-based stats.
Identities = 30/75 (40%), Positives = 45/75 (60%), Gaps = 1/75 (1%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V AFL + +V+ +KLAS + ++ K +DD L++ L L ++ VL +AE K
Sbjct: 1 MAELVAGAFLQSSFQVIFEKLASVDIRDYFSSKNVDD-LVKELNIALNSINHVLEEAEIK 59
Query: 61 QIKDSAVNKWLDDLK 75
Q + V KWLD LK
Sbjct: 60 QYQIIYVKKWLDKLK 74
>Medtr3g023030.1 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:6950546-6944739 | 20130731
Length = 1159
Score = 52.8 bits (125), Expect = 7e-08, Method: Composition-based stats.
Identities = 31/77 (40%), Positives = 48/77 (62%), Gaps = 3/77 (3%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V AFL + +V+I+KLAS ++ +DD L++ L + L ++ VL++AE K
Sbjct: 1 MAELVAGAFLQSSFQVIIEKLASVGIRDYFSSNNVDD-LVKELHSALDSINLVLDEAEIK 59
Query: 61 QIKDSAVN--KWLDDLK 75
Q + VN KWLD+LK
Sbjct: 60 QYQKKYVNVKKWLDELK 76
>Medtr3g023030.2 | LRR and NB-ARC domain disease resistance
protein | LC | chr3:6950564-6944739 | 20130731
Length = 1159
Score = 52.8 bits (125), Expect = 7e-08, Method: Composition-based stats.
Identities = 31/77 (40%), Positives = 48/77 (62%), Gaps = 3/77 (3%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V AFL + +V+I+KLAS ++ +DD L++ L + L ++ VL++AE K
Sbjct: 1 MAELVAGAFLQSSFQVIIEKLASVGIRDYFSSNNVDD-LVKELHSALDSINLVLDEAEIK 59
Query: 61 QIKDSAVN--KWLDDLK 75
Q + VN KWLD+LK
Sbjct: 60 QYQKKYVNVKKWLDELK 76
>Medtr3g027200.1 | NB-ARC domain disease resistance protein | LC |
chr3:8455781-8451620 | 20130731
Length = 1164
Score = 52.8 bits (125), Expect = 8e-08, Method: Composition-based stats.
Identities = 29/75 (38%), Positives = 46/75 (61%), Gaps = 1/75 (1%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V AFL + +++I+KLAS + ++ +D L + L L ++ VL++AE K
Sbjct: 1 MAELVAGAFLQSSFQLIIEKLASVDIRDYFSSNNVD-ALAKELNIALDSINQVLDEAEIK 59
Query: 61 QIKDSAVNKWLDDLK 75
Q ++ V KWLDDLK
Sbjct: 60 QYQNKYVKKWLDDLK 74
>Medtr2g038900.1 | NBS-LRR type disease resistance protein | LC |
chr2:17026953-17030684 | 20130731
Length = 1243
Score = 52.8 bits (125), Expect = 8e-08, Method: Composition-based stats.
Identities = 29/72 (40%), Positives = 41/72 (56%), Gaps = 8/72 (11%)
Query: 6 GEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIKDS 65
G A S+F E +IDKL+S E D+NL RL L+++ V +DAE+KQI +
Sbjct: 7 GGAIASSFFEALIDKLSSAE--------TXDENLHSRLITALFSINVVADDAEKKQIXNF 58
Query: 66 AVNKWLDDLKDA 77
V +WL +KD
Sbjct: 59 HVKEWLLGVKDG 70
>Medtr7g021000.1 | disease resistance protein (CC-NBS-LRR class)
family protein | LC | chr7:6572250-6575717 | 20130731
Length = 1132
Score = 52.4 bits (124), Expect = 9e-08, Method: Composition-based stats.
Identities = 26/75 (34%), Positives = 47/75 (62%), Gaps = 5/75 (6%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA ++ AFLS+F +V +++ AS +F + + L+++L+ T+ ++ +L+DAE K
Sbjct: 1 MAELIAGAFLSSFFQVTLERFASRDFKDL-----FNKGLVEKLEITMNSINQLLDDAETK 55
Query: 61 QIKDSAVNKWLDDLK 75
Q ++ V WLD LK
Sbjct: 56 QYQNPNVKIWLDRLK 70
>Medtr3g070590.1 | LRR and NB-ARC domain disease resistance
protein | HC | chr3:31663955-31668558 | 20130731
Length = 1068
Score = 52.4 bits (124), Expect = 1e-07, Method: Composition-based stats.
Identities = 29/76 (38%), Positives = 49/76 (64%), Gaps = 1/76 (1%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA ++G +FLS+ + +D+++ +F +F +G +D+ LQ L+ L +V VLNDAE+K
Sbjct: 1 MAEILG-SFLSSLLASKVDRISVQDFKDFFKGNGIDERHLQDLRLLLLSVATVLNDAEEK 59
Query: 61 QIKDSAVNKWLDDLKD 76
Q + V +W D +KD
Sbjct: 60 QFIEPWVKEWTDKVKD 75
>Medtr3g071130.2 | LRR and NB-ARC domain disease resistance
protein | HC | chr3:31930414-31927082 | 20130731
Length = 1110
Score = 52.0 bits (123), Expect = 1e-07, Method: Composition-based stats.
Identities = 29/76 (38%), Positives = 49/76 (64%), Gaps = 1/76 (1%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA ++G +FLS+ + +D+++ +F +F +G +D+ LQ L+ L +V VLNDAE+K
Sbjct: 1 MAEILG-SFLSSLLPSKVDRISVQDFKDFFKGNGIDEGHLQDLRLLLLSVATVLNDAEEK 59
Query: 61 QIKDSAVNKWLDDLKD 76
Q + V +W D +KD
Sbjct: 60 QFIEPWVKEWTDKVKD 75
>Medtr3g071130.1 | LRR and NB-ARC domain disease resistance
protein | HC | chr3:31930414-31927082 | 20130731
Length = 1110
Score = 52.0 bits (123), Expect = 1e-07, Method: Composition-based stats.
Identities = 29/76 (38%), Positives = 49/76 (64%), Gaps = 1/76 (1%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA ++G +FLS+ + +D+++ +F +F +G +D+ LQ L+ L +V VLNDAE+K
Sbjct: 1 MAEILG-SFLSSLLPSKVDRISVQDFKDFFKGNGIDEGHLQDLRLLLLSVATVLNDAEEK 59
Query: 61 QIKDSAVNKWLDDLKD 76
Q + V +W D +KD
Sbjct: 60 QFIEPWVKEWTDKVKD 75
>Medtr7g021000.2 | disease resistance protein (CC-NBS-LRR class)
family protein | LC | chr7:6571404-6576833 | 20130731
Length = 849
Score = 52.0 bits (123), Expect = 1e-07, Method: Composition-based stats.
Identities = 26/75 (34%), Positives = 47/75 (62%), Gaps = 5/75 (6%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA ++ AFLS+F +V +++ AS +F + + L+++L+ T+ ++ +L+DAE K
Sbjct: 1 MAELIAGAFLSSFFQVTLERFASRDFKDL-----FNKGLVEKLEITMNSINQLLDDAETK 55
Query: 61 QIKDSAVNKWLDDLK 75
Q ++ V WLD LK
Sbjct: 56 QYQNPNVKIWLDRLK 70
>Medtr3g021340.1 | LRR and NB-ARC domain disease resistance
protein, putative | LC | chr3:6246570-6241450 |
20130731
Length = 1136
Score = 52.0 bits (123), Expect = 1e-07, Method: Composition-based stats.
Identities = 26/70 (37%), Positives = 46/70 (65%), Gaps = 5/70 (7%)
Query: 4 VVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIK 63
VV AFLS I+++ ++LAS +F ++ L + L+++L+ TL ++ VL+DAE K+ +
Sbjct: 5 VVRRAFLSPVIQLICERLASTDFSDY-----LHEKLVKKLEITLVSINQVLDDAETKKYE 59
Query: 64 DSAVNKWLDD 73
+ V W+DD
Sbjct: 60 NQNVKNWVDD 69
>Medtr3g022400.1 | disease resistance protein (CC-NBS-LRR class)
family protein | LC | chr3:6590310-6593729 | 20130731
Length = 1139
Score = 52.0 bits (123), Expect = 1e-07, Method: Composition-based stats.
Identities = 29/75 (38%), Positives = 47/75 (62%), Gaps = 5/75 (6%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA V+ AFLS+ V+ +KLAS +F N+ + L ++L+ TL ++ VL++A+ K
Sbjct: 1 MAGVIDGAFLSSVFLVIREKLASRDFRNYFH-----EMLRKKLEITLDSINEVLDEADVK 55
Query: 61 QIKDSAVNKWLDDLK 75
+ + V KWLDD+K
Sbjct: 56 EYQHRNVRKWLDDIK 70
>Medtr3g022400.2 | disease resistance protein (CC-NBS-LRR class)
family protein | LC | chr3:6590310-6593729 | 20130731
Length = 1111
Score = 52.0 bits (123), Expect = 1e-07, Method: Composition-based stats.
Identities = 29/75 (38%), Positives = 47/75 (62%), Gaps = 5/75 (6%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA V+ AFLS+ V+ +KLAS +F N+ + L ++L+ TL ++ VL++A+ K
Sbjct: 1 MAGVIDGAFLSSVFLVIREKLASRDFRNYFH-----EMLRKKLEITLDSINEVLDEADVK 55
Query: 61 QIKDSAVNKWLDDLK 75
+ + V KWLDD+K
Sbjct: 56 EYQHRNVRKWLDDIK 70
>Medtr3g021380.1 | NBS-LRR type disease resistance protein | LC |
chr3:6260285-6256594 | 20130731
Length = 1132
Score = 51.6 bits (122), Expect = 1e-07, Method: Composition-based stats.
Identities = 28/71 (39%), Positives = 41/71 (57%), Gaps = 5/71 (7%)
Query: 6 GEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIKDS 65
G AFLS I ++ LAS +F ++ D L+ +L+ TL + VL+DAE KQ +D
Sbjct: 10 GGAFLSPVIRLICKSLASTDFRDY-----FDKGLVNKLETTLNFINLVLDDAETKQYEDL 64
Query: 66 AVNKWLDDLKD 76
V WLDD+ +
Sbjct: 65 GVKCWLDDVSN 75
>Medtr7g089080.1 | cyclin | HC | chr7:34806771-34800306 | 20130731
Length = 1318
Score = 51.2 bits (121), Expect = 2e-07, Method: Composition-based stats.
Identities = 27/58 (46%), Positives = 33/58 (56%), Gaps = 20/58 (34%)
Query: 20 KLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIKDSAVNKWLDDLKDA 77
+L+SP+ + IRGK++D NL KQIKDSAVN WLDDLKDA
Sbjct: 461 RLSSPQILELIRGKQVDVNL--------------------KQIKDSAVNNWLDDLKDA 498
>Medtr3g022230.3 | NB-ARC domain disease resistance protein,
putative | LC | chr3:6519072-6523865 | 20130731
Length = 1597
Score = 51.2 bits (121), Expect = 2e-07, Method: Composition-based stats.
Identities = 28/75 (37%), Positives = 44/75 (58%), Gaps = 1/75 (1%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V AFL + +V+ +KLAS ++ +D L + L + L ++ VL +AE K
Sbjct: 1 MAELVAGAFLQSSFQVIFEKLASVHIRDYFSSDNVD-ALAKELDHKLNSINHVLEEAELK 59
Query: 61 QIKDSAVNKWLDDLK 75
Q ++ V KWLD+LK
Sbjct: 60 QYQNKYVKKWLDELK 74
>Medtr3g022230.4 | NB-ARC domain disease resistance protein,
putative | LC | chr3:6519072-6523865 | 20130731
Length = 1597
Score = 51.2 bits (121), Expect = 2e-07, Method: Composition-based stats.
Identities = 28/75 (37%), Positives = 44/75 (58%), Gaps = 1/75 (1%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V AFL + +V+ +KLAS ++ +D L + L + L ++ VL +AE K
Sbjct: 1 MAELVAGAFLQSSFQVIFEKLASVHIRDYFSSDNVD-ALAKELDHKLNSINHVLEEAELK 59
Query: 61 QIKDSAVNKWLDDLK 75
Q ++ V KWLD+LK
Sbjct: 60 QYQNKYVKKWLDELK 74
>Medtr3g022230.2 | NB-ARC domain disease resistance protein,
putative | LC | chr3:6519072-6523865 | 20130731
Length = 1597
Score = 51.2 bits (121), Expect = 2e-07, Method: Composition-based stats.
Identities = 28/75 (37%), Positives = 44/75 (58%), Gaps = 1/75 (1%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V AFL + +V+ +KLAS ++ +D L + L + L ++ VL +AE K
Sbjct: 1 MAELVAGAFLQSSFQVIFEKLASVHIRDYFSSDNVD-ALAKELDHKLNSINHVLEEAELK 59
Query: 61 QIKDSAVNKWLDDLK 75
Q ++ V KWLD+LK
Sbjct: 60 QYQNKYVKKWLDELK 74
>Medtr3g022230.1 | NB-ARC domain disease resistance protein,
putative | LC | chr3:6519072-6523865 | 20130731
Length = 1597
Score = 51.2 bits (121), Expect = 2e-07, Method: Composition-based stats.
Identities = 28/75 (37%), Positives = 44/75 (58%), Gaps = 1/75 (1%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V AFL + +V+ +KLAS ++ +D L + L + L ++ VL +AE K
Sbjct: 1 MAELVAGAFLQSSFQVIFEKLASVHIRDYFSSDNVD-ALAKELDHKLNSINHVLEEAELK 59
Query: 61 QIKDSAVNKWLDDLK 75
Q ++ V KWLD+LK
Sbjct: 60 QYQNKYVKKWLDELK 74
>Medtr3g022230.5 | NB-ARC domain disease resistance protein,
putative | LC | chr3:6519072-6523865 | 20130731
Length = 1597
Score = 51.2 bits (121), Expect = 2e-07, Method: Composition-based stats.
Identities = 28/75 (37%), Positives = 44/75 (58%), Gaps = 1/75 (1%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA +V AFL + +V+ +KLAS ++ +D L + L + L ++ VL +AE K
Sbjct: 1 MAELVAGAFLQSSFQVIFEKLASVHIRDYFSSDNVD-ALAKELDHKLNSINHVLEEAELK 59
Query: 61 QIKDSAVNKWLDDLK 75
Q ++ V KWLD+LK
Sbjct: 60 QYQNKYVKKWLDELK 74
>Medtr3g027420.1 | NBS-LRR type disease resistance protein | LC |
chr3:8567848-8571959 | 20130731
Length = 1145
Score = 50.8 bits (120), Expect = 3e-07, Method: Composition-based stats.
Identities = 28/75 (37%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
MA ++ AFLS+ +V I +LAS +F R L++ L+ TL ++ +L+DAE K
Sbjct: 1 MAELIAGAFLSSVFQVTIQRLASRDFRGCFR-----KGLVEELEITLNSINQLLDDAETK 55
Query: 61 QIKDSAVNKWLDDLK 75
Q +++ V WL LK
Sbjct: 56 QYQNTYVKNWLHKLK 70
>Medtr3g022920.1 | disease resistance protein (CC-NBS-LRR class)
family protein | LC | chr3:6901155-6897741 | 20130731
Length = 1135
Score = 50.1 bits (118), Expect = 5e-07, Method: Composition-based stats.
Identities = 26/75 (34%), Positives = 47/75 (62%), Gaps = 5/75 (6%)
Query: 1 MAAVVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQK 60
M+ VVG FLS+ V+ ++LAS + +++ ++ ++L+ TL ++ VL+DA+ K
Sbjct: 1 MSEVVGGTFLSSVFRVIFERLASTDCRDYVHV-----DVEKKLEITLVSINKVLDDAKAK 55
Query: 61 QIKDSAVNKWLDDLK 75
Q ++ V WL+DLK
Sbjct: 56 QYRNKNVRNWLNDLK 70
>Medtr3g021170.1 | LRR and NB-ARC domain disease resistance
protein, putative | LC | chr3:6169981-6166550 |
20130731
Length = 1143
Score = 50.1 bits (118), Expect = 5e-07, Method: Composition-based stats.
Identities = 25/73 (34%), Positives = 46/73 (63%), Gaps = 5/73 (6%)
Query: 4 VVGEAFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIK 63
VV AFLS I+++ ++LAS + ++ K + ++L+ TL ++ VL+DAE KQ +
Sbjct: 5 VVRRAFLSPVIQLICERLASTDLSDYFHEKHV-----KKLEITLVSINKVLDDAETKQYE 59
Query: 64 DSAVNKWLDDLKD 76
+ V W+DD+++
Sbjct: 60 NLDVKNWVDDIRN 72
>Medtr8g011300.1 | NBS-LRR type disease resistance protein | LC |
chr8:2988670-2992412 | 20130731
Length = 979
Score = 48.5 bits (114), Expect = 1e-06, Method: Composition-based stats.
Identities = 28/60 (46%), Positives = 38/60 (63%), Gaps = 1/60 (1%)
Query: 17 VIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIKDSAVNKWLDDLKD 76
++++LAS F F R + D L +RLKNT+ + AVL DAE+KQ K AV W+ LKD
Sbjct: 13 LVNRLASAAFREFGRIYGVMDEL-ERLKNTIEVIRAVLLDAEEKQEKSPAVQVWVRRLKD 71
>Medtr3g026660.2 | NB-ARC domain disease resistance protein | HC |
chr3:8188700-8184619 | 20130731
Length = 1100
Score = 47.8 bits (112), Expect = 2e-06, Method: Composition-based stats.
Identities = 31/71 (43%), Positives = 40/71 (56%), Gaps = 11/71 (15%)
Query: 12 AFIEVVIDKLASPEFVNFIRGKKLD-----DNLLQRLKNTLYAVEAVLNDAEQKQIKDSA 66
A IEVV++ L+S + KKLD D L+ L + L ++A L DAE+KQ D A
Sbjct: 4 AVIEVVLNNLSS------LAQKKLDLFLSFDQDLKSLASLLTTIKATLEDAEEKQFTDRA 57
Query: 67 VNKWLDDLKDA 77
V WL LKDA
Sbjct: 58 VKDWLIKLKDA 68
>Medtr3g026660.1 | NB-ARC domain disease resistance protein | HC |
chr3:8188700-8184619 | 20130731
Length = 1157
Score = 47.8 bits (112), Expect = 3e-06, Method: Composition-based stats.
Identities = 31/71 (43%), Positives = 40/71 (56%), Gaps = 11/71 (15%)
Query: 12 AFIEVVIDKLASPEFVNFIRGKKLD-----DNLLQRLKNTLYAVEAVLNDAEQKQIKDSA 66
A IEVV++ L+S + KKLD D L+ L + L ++A L DAE+KQ D A
Sbjct: 4 AVIEVVLNNLSS------LAQKKLDLFLSFDQDLKSLASLLTTIKATLEDAEEKQFTDRA 57
Query: 67 VNKWLDDLKDA 77
V WL LKDA
Sbjct: 58 VKDWLIKLKDA 68
>Medtr3g021400.1 | disease resistance protein (CC-NBS-LRR class)
family protein, putative | LC | chr3:6266957-6261805 |
20130731
Length = 1135
Score = 47.4 bits (111), Expect = 3e-06, Method: Composition-based stats.
Identities = 23/66 (34%), Positives = 42/66 (63%), Gaps = 5/66 (7%)
Query: 8 AFLSAFIEVVIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIKDSAV 67
AFLS I+ + ++L+S +F ++R + L ++L+ TL ++ VL+DAE K+ ++ V
Sbjct: 2 AFLSPIIQEICERLSSTDFGGYVR-----EELGKKLEITLVSINQVLDDAETKKYENQNV 56
Query: 68 NKWLDD 73
W+DD
Sbjct: 57 KNWVDD 62
>Medtr8g011550.1 | NB-ARC domain disease resistance protein | LC |
chr8:3142903-3139894 | 20130731
Length = 932
Score = 47.4 bits (111), Expect = 3e-06, Method: Composition-based stats.
Identities = 28/60 (46%), Positives = 39/60 (65%), Gaps = 1/60 (1%)
Query: 17 VIDKLASPEFVNFIRGKKLDDNLLQRLKNTLYAVEAVLNDAEQKQIKDSAVNKWLDDLKD 76
++++LAS F F R + D L +RLKNT+ +++AVL DAE KQ K AV W+ LKD
Sbjct: 13 LVNRLASAAFREFGRIYGVMDEL-ERLKNTVESIKAVLLDAEDKQEKSHAVQIWIRRLKD 71
>Medtr5g072140.1 | NB-ARC domain disease resistance protein | HC |
chr5:30675543-30682407 | 20130731
Length = 940
Score = 45.8 bits (107), Expect = 8e-06, Method: Composition-based stats.
Identities = 20/38 (52%), Positives = 28/38 (73%)
Query: 40 LQRLKNTLYAVEAVLNDAEQKQIKDSAVNKWLDDLKDA 77
+Q+L N L ++AVL DAE+KQ K+ ++ WL DLKDA
Sbjct: 31 VQKLSNNLVHIKAVLEDAEKKQFKELSIKLWLQDLKDA 68